OBI-992

· OBI Pharma, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OBI-992, covering 2025-08-08 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]